VOYA Investment Management
INBX

VOYA Investment Management’s Inhibrx, Inc. Common Stock INBX Stock Holding History

VOYA Investment Management’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-11,346
Closed -$397K – 2947
2024
Q1 		$397K Sell
11,346
-2,753
-20% -$100K ﹤0.01% 2118
2023
Q4 		$536K Buy
14,099
+234
+2% +$5.01K ﹤0.01% 2042
2023
Q3 		$254K Buy
13,865
+227
+2% +$4.75K ﹤0.01% 2400
2023
Q2 		$354K Buy
13,638
+1,081
+9% +$25.2K ﹤0.01% 2271
2023
Q1 		$237K Hold
12,557
– – ﹤0.01% 2441
2022
Q4 		$309K Buy
12,557
+784
+7% +$23K ﹤0.01% 2312
2022
Q3 		$211K Buy
11,773
+843
+8% +$15.2K ﹤0.01% 2577
2022
Q2 		$124K Hold
10,930
– – ﹤0.01% 2564
2022
Q1 		$244K Hold
10,930
– – ﹤0.01% 2270
2021
Q4 		$477K Sell
10,930
-224
-2% -$8.96K ﹤0.01% 2057
2021
Q3 		$372K Hold
11,154
– – ﹤0.01% 2220
2021
Q2 		$307K Buy
+11,154
New +$232K ﹤0.01% 2365

Other funds holding INBX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

VOYA Investment Management's INBX Position: Q2 2024 in Review

VOYA Investment Management sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 11,346 shares — an estimated $397K sold.

VOYA Investment Management first reported a position in INBX in Q2 2021 and held it in 12 quarters. The position peaked at $536K in Q4 2023. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

  • VOYA Investment Management reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • VOYA Investment Management sold 11,346 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $397K.
  • VOYA Investment Management first reported a position in Inhibrx, Inc. Common Stock in Q2 2021 and held it in 12 quarters.
  • VOYA Investment Management's Inhibrx, Inc. Common Stock position peaked at $536K in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on VOYA Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.